Parallel study as pilot for long half life drug [Design Issues]

posted by jag009  – NJ, 2012-05-07 20:15 (5164 d 19:50 ago) – Posting: # 8527
Views: 5,718

Dear Dan,

I don't see how I can proceed with a pivtoal crossover study later. The CV (total CV) obtained from the parallel pilot study is not appropriate for estimating the crossover study sample size since one cannot extract the intraCV from the total CV.

The dilemma I have now is timing... If I go with a crossover pilot --> probably 16 day sampling and 30 day washout --> bloody long study...
If I go with parallel study then cost will be a factor... Double edge sword...


John

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
325 visitors (0 registered, 325 guests [including 15 identified bots]).
Forum time: 16:06 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5